Pharmaceutical compositions comprising monoterpenes
    201.
    发明授权
    Pharmaceutical compositions comprising monoterpenes 有权
    包含单萜的药物组合物

    公开(公告)号:US09133085B2

    公开(公告)日:2015-09-15

    申请号:US13939834

    申请日:2013-07-11

    Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

    Abstract translation: 本发明提供纯化大于约98.5%(w / w)的单萜或倍半萜的方法。 该方法包括衍生单萜(或倍半萜烯)以产生单萜(或倍半萜烯)衍生物,分离单萜(或倍半萜烯)衍生物和从衍生物中释放单萜(或倍半萜烯)的步骤。 包括本发明范围的药物组合物是包含纯度大于约98.5%(w / w)的单萜(或倍半萜烯)的药物组合物。 纯化的单萜可用于治疗癌症等疾病。 本单萜(或倍半萜烯)可以单独施用,或者可以与辐射或其它治疗剂如化学治疗剂共同施用。

    GAMMA AMINO ACID BUILDING BLOCKS
    205.
    发明申请
    GAMMA AMINO ACID BUILDING BLOCKS 有权
    GAMMA氨基酸建筑块

    公开(公告)号:US20150148523A1

    公开(公告)日:2015-05-28

    申请号:US14166007

    申请日:2014-01-28

    Abstract: The invention provides compounds and methods, for example, to carry out organocatalytic Michael additions of aldehydes to cyclically constrained nitroethylene compounds catalyzed by a proline derivative to provide cyclically constrained α-substituted-γ-nitro-aldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96 to >99% e.e.).The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to cyclically constrained protected γ-amino acid residues, which are essential for systematic conformational studies of γ-peptide foldamers. New methods are also provided to prepare other γ-amino acids and peptides. These new building blocks can be used to prepare foldamers, such as α/γ-peptide foldamers, that adopt specific helical conformations in solution and in the solid state.

    Abstract translation: 本发明提供了化合物和方法,例如,进行有机催化迈克尔加成醛到由脯氨酸衍生物催化的周期受限的硝基乙烯化合物以提供循环约束的α-取代的γ-硝基醛。 当使用手性吡咯烷催化剂时,可以使反应呈现对映选择性,允许以几乎光学纯的形式(例如,96至> 99%e.e。)的迈克尔加合物。 迈克尔加合物可以承受单个取代基或与羰基相邻的双取代基。 迈克尔加合物可以有效地转化为循环受限的受保护的γ-氨基酸残基,这对于γ-肽折叠物的系统构象研究至关重要。 还提供了新的方法来制备其它γ-氨基酸和肽。 这些新的构建块可用于制备在溶液中和固体状态下采用特定螺旋构象的折叠物,例如α/γ-肽折叠物。

    New Alkylaromatic Process
    210.
    发明申请
    New Alkylaromatic Process 有权
    新的烷基芳烃工艺

    公开(公告)号:US20130150607A1

    公开(公告)日:2013-06-13

    申请号:US13313380

    申请日:2011-12-07

    Inventor: Beth A. WINSETT

    Abstract: This invention is directed to a new process for making an alkylaromatic compound. In an embodiment of this invention, the process is directed to selective synthesizing an alkylaromatic compound comprising a high amount of dialkylate product. In general, this process involves contacting at least one alkylatable aromatic compound with an alkylating agent and a catalyst under suitable reaction conditions such that the resulting reactor effluent prior to any stripping step may be characterized by a dialkylate product content of at least 44 wt % and a trialkylate and higher polyalkylate product content of no more than 20 wt %. The alkylaromatic compounds produced have excellent thermal and oxidative stabilities, good additive solvency, and improved seal compatibility while maintaining good VI and low temperature properties. They are useful as lubricant basestocks and lubricant additives.

    Abstract translation: 本发明涉及制备烷基芳族化合物的新方法。 在本发明的一个实施方案中,该方法涉及选择性合成包含大量二烷基酯产物的烷基芳族化合物。 通常,该方法包括在合适的反应条件下使至少一种可烷基化芳族化合物与烷基化剂和催化剂接触,使得在任何汽提步骤之前的所得反应器流出物的特征在于二烷基化物产物含量为至少44重量%,和 三烷基化物和较高的多烷基化产物含量不超过20重量%。 生产的烷基芳族化合物具有优异的热和氧化稳定性,良好的添加剂溶解性和改善的密封相容性,同时保持良好的VI和低温性能。 它们可用作润滑剂基础油和润滑剂添加剂。

Patent Agency Ranking